Exendin affects beta-cell function and insulin secretion
Exendin analogs consistently demonstrate positive effects on beta-cell function, survival, and insulin secretion across multiple experimental and clinical studies.
The claim is specific, testable, and well-supported by experimental and clinical studies showing that exendin (such as exendin-4) interacts with GLP-1 receptors on pancreatic beta cells to modulate insulin secretion, improve mitochondrial health, reduce apoptosis, and preserve beta-cell mass.
Sakaki K, Murakami T, Yoshida H, Otani D, Miyake KK, Shimizu Y, Fujimoto H, Yabe D, Nakamoto Y, Inagaki N. Quantitative β-Cell Mass Imaging Redefines Disease Staging and Glycemic Control in Type 1 Diabetes.. 2026. https://doi.org/10.2337/db25-1127
Paper 1 demonstrates that exendin-based tracers bind to pancreatic beta cells and correlate with beta-cell function markers like C-peptide and glycemic control.
See more details
Zhao J, Ling X, Fan S, Sun Z, Huang X, Fu H, Liu H, Xing Y, Zhu X. Exendin-4 improves high glucose-induced mitochondrial dysfunction of pancreatic β-cells via PKA/Drp1 signaling.. 2026. https://doi.org/10.1530/joe-26-0023
Paper 4 shows that exendin-4 protects beta cells from mitochondrial dysfunction and improves glucose-stimulated insulin secretion.
Sridhar A, Palmer ES, Craig SL, Krason-Kidzinska E, Irwin N, O'Harte FPM. Unimolecular GLP-1/Apelin Hybrid Peptides Cause Prominent Appetite Suppression, as Well as Enhancing Insulin Secretion, Beta-Cell Survival and Glycaemic Regulation.. 2026. https://doi.org/10.1111/dom.70647
Paper 5 reports that exendin-4 hybrid peptides enhance insulin secretion and promote beta-cell survival.
Yamazaki H, Tokgöz S, Tauchi S, Nakamura F, Dohke M, Hanawa N, Kodama Y, Katanuma A, Yamamoto Y, Fukuhara S, Prystupa K, Hummel J, Deden L, Boss M, Gotthardt M, Wagner R, Heni M. Structural determinants of beta-cell failure in type 2 diabetes: a multimodality imaging study.. 2026. https://doi.org/10.1016/j.metabol.2026.156631
Paper 7 links exendin-4 PET/CT estimates of beta-cell mass to insulin secretion rates in patients.
Van de Velde S, Yu J, Garrett Evensen K, Pakhlevanyan E, Williams AE, Shaw RJ, Montminy M. Med14 phosphorylation shapes genomic response to GLP-1 agonists.. 2026. https://doi.org/10.1073/pnas.2536772123
Paper 10 notes that chronic exposure to exendin-4 stimulates sustained gene expression leading to increased beta-cell viability and insulin secretion.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt